The origin of bladder cancer from mucosal field effects.
Cancer
Cell biology
Molecular biology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
15 Jul 2022
15 Jul 2022
Historique:
received:
24
09
2021
revised:
19
11
2021
accepted:
02
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Whole-organ mapping was used to study molecular changes in the evolution of bladder cancer from field effects. We identified more than 100 dysregulated pathways, involving immunity, differentiation, and transformation, as initiators of carcinogenesis. Dysregulation of interleukins signified the involvement of inflammation in the incipient phases of the process. An aberrant methylation/expression of multiple
Identifiants
pubmed: 35747385
doi: 10.1016/j.isci.2022.104551
pii: S2589-0042(22)00823-9
pmc: PMC9209726
doi:
Types de publication
Journal Article
Langues
eng
Pagination
104551Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
We confirm that there are no competing interests.
Références
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13732-7
pubmed: 17702869
Cell Rep. 2019 May 7;27(6):1781-1793.e4
pubmed: 31067463
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6329-34
pubmed: 24722637
Mol Cancer Ther. 2015 Jan;14(1):174-82
pubmed: 25349305
Int J Oncol. 2012 Nov;41(5):1577-86
pubmed: 22922995
Clin Cancer Res. 2021 Mar 1;27(5):1538-1552
pubmed: 33479048
NPJ Breast Cancer. 2018 Jun 25;4:13
pubmed: 29951581
BMC Cancer. 2013 Jul 01;13:322
pubmed: 23815949
Cancer Res. 2014 Apr 1;74(7):2026-37
pubmed: 24523441
Sci Rep. 2018 Oct 17;8(1):15304
pubmed: 30333500
Annu Rev Pathol. 2016 May 23;11:149-74
pubmed: 26907529
Bioinformatics. 2012 Aug 15;28(16):2184-5
pubmed: 22743226
Nat Immunol. 2017 Feb;18(2):214-224
pubmed: 27992402
N Engl J Med. 2012 Jan 12;366(2):141-9
pubmed: 22236224
Cancer Biol Med. 2016 Jun;13(2):277-85
pubmed: 27458535
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
J Biol Chem. 2013 Feb 1;288(5):3275-88
pubmed: 23239884
Mol Cell Biol. 2021 May 21;41(6):e0036320
pubmed: 33288643
iScience. 2020 Jun 26;23(6):101201
pubmed: 32521509
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Eur Urol. 2003 Mar;43(3):309-19
pubmed: 12600436
Nat Genet. 2016 Jan;48(1):12-21
pubmed: 26618344
Eur J Cell Biol. 2005 Mar;84(2-3):393-405
pubmed: 15819416
Sci Rep. 2016 Nov 22;6:36540
pubmed: 27874022
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9649-54
pubmed: 15980150
Oncol Lett. 2019 Jul;18(1):15-21
pubmed: 31289466
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28423402
Eur J Cell Biol. 2014 Oct;93(10-12):466-77
pubmed: 25022758
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Science. 2020 Oct 2;370(6512):75-82
pubmed: 33004514
PLoS One. 2019 Feb 25;14(2):e0212813
pubmed: 30802265
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Med. 2018 Jan;7(1):184-195
pubmed: 29239139
Science. 2020 Oct 2;370(6512):82-89
pubmed: 33004515
Oncogene. 2005 Nov 24;24(53):7821-9
pubmed: 16027728
Comput Struct Biotechnol J. 2019 May 23;17:661-674
pubmed: 31205619
DNA Cell Biol. 2013 Jul;32(7):386-92
pubmed: 23682613
Nature. 2019 Dec;576(7787):471-476
pubmed: 31827283
Cancer Cell. 2014 Feb 10;25(2):152-65
pubmed: 24525232
Urol Oncol. 2013 Oct;31(7):1184-92
pubmed: 24075358
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Genome Med. 2017 Apr 18;9(1):35
pubmed: 28420412
Nat Rev Cancer. 2010 May;10(5):361-71
pubmed: 20357775
Biochem Biophys Res Commun. 1998 Oct 9;251(1):158-65
pubmed: 9790924
EBioMedicine. 2020 Mar;53:102701
pubmed: 32151798
Lab Invest. 2008 Jul;88(7):694-721
pubmed: 18458673
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Cell Death Dis. 2020 May 7;11(5):336
pubmed: 32382053
Cancer Treat Rev. 2020 Nov;90:102091
pubmed: 32877777
Evolution. 2011 Mar;65(3):661-72
pubmed: 21054360
Nat Cell Biol. 2014 May;16(5):469-78
pubmed: 24747439
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
EMBO Rep. 2020 Dec 3;21(12):e50155
pubmed: 33063451
Int J Cancer. 2015 Feb 15;136(4):844-53
pubmed: 24948044
Cancer Manag Res. 2018 May 01;10:969-976
pubmed: 29760566
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Nat Cell Biol. 2014 Oct;16(10):982-91, 1-5
pubmed: 25218638
Nucleic Acids Res. 2018 Jul 27;46(13):6608-6626
pubmed: 29846670
Genome Res. 2007 Nov;17(11):1665-74
pubmed: 17921354
BMC Proc. 2009 Jul 16;3 Suppl 4:S6
pubmed: 19615119
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Sci Rep. 2020 Jun 16;10(1):9743
pubmed: 32546765
Cladistics. 1999 Dec;15(4):407-414
pubmed: 34902938
J Invest Surg. 2022 Feb;35(2):442-447
pubmed: 33292020
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Matrix Biol. 2007 Jan;26(1):30-41
pubmed: 17074475
Stat Methods Med Res. 2018 Oct;27(10):3026-3038
pubmed: 28164740
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Bioinformatics. 2015 Aug 1;31(15):2565-7
pubmed: 25819670
BMC Cancer. 2018 Aug 6;18(1):786
pubmed: 30081853
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Oncologist. 2015 Oct;20(10):1189-98
pubmed: 26306903
J Invest Dermatol. 2015 May;135(5):1253-1260
pubmed: 25615553
Hum Mutat. 2015 Apr;36(4):E2423-9
pubmed: 25703262
Bioengineered. 2021 Dec;12(2):9377-9389
pubmed: 34818994
Mol Cancer. 2018 Aug 7;17(1):115
pubmed: 30086763
CRC Crit Rev Clin Lab Sci. 1978;9(3):209-42
pubmed: 401370
World J Urol. 2019 Oct;37(10):2001-2007
pubmed: 31028457
Cell Rep. 2019 Feb 19;26(8):2241-2256.e4
pubmed: 30784602
Clin Cancer Res. 2009 May 1;15(9):2954-61
pubmed: 19383829
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
Clin Cancer Res. 2013 Jan 1;19(1):279-90
pubmed: 23091115
Cancer Res. 2021 Mar 15;81(6):1552-1566
pubmed: 33472889
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
Invest Ophthalmol Vis Sci. 2012 Oct 25;53(11):7382-8
pubmed: 23033384
Sci Rep. 2017 Sep 15;7(1):11702
pubmed: 28916750
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
EBioMedicine. 2016 Oct;12:105-117
pubmed: 27612592
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
BMC Biochem. 2010 Apr 29;11:18
pubmed: 20429931
Nat Biomed Eng. 2017;1:714-723
pubmed: 29805844
Curr Cancer Drug Targets. 2020;20(9):647-653
pubmed: 32479243
Cell. 2018 Feb 8;172(4):650-665
pubmed: 29425488
J Clin Invest. 2020 Jun 1;130(6):3137-3150
pubmed: 32125291
Oncotarget. 2017 Jan 10;8(2):2114-2129
pubmed: 27924063
Genome Biol. 2010;11(9):R92
pubmed: 20858232